Berlin, Germany

Joachim F Kapp

This inventor holds 1 USPTO granted patent. Top assignee: Schering Aktiengesellschaft. Active years: 1981.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Joachim F Kapp. Retrieved from https://idiyas.com/inventor/joachim-f-kapp

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 1981

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Joachim F. Kapp

Introduction

Joachim F. Kapp is a notable inventor based in Berlin, Germany. He is recognized for his contributions to the field of pharmaceuticals, particularly in the development of novel corticoids. His work has significant implications for anti-inflammatory treatments.

Latest Patents

Kapp holds a patent for novel corticoids characterized by a specific formula. These corticoids, defined by the formula I ##STR1##, exhibit strong anti-inflammatory activity when administered topically. They are designed to minimize systemic side effects, making them a valuable addition to therapeutic options.

Career Highlights

Throughout his career, Kapp has been associated with Schering Aktiengesellschaft, a prominent pharmaceutical company. His work there has focused on advancing medical treatments through innovative research and development.

Collaborations

Kapp has collaborated with esteemed colleagues, including Klaus Annen and Henry Laurent. These partnerships have contributed to the success of his research and the development of effective pharmaceutical solutions.

Conclusion

Joachim F. Kapp's contributions to the field of pharmaceuticals, particularly through his patent on novel corticoids, highlight his innovative spirit and dedication to improving medical treatments. His work continues to influence the landscape of anti-inflammatory therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…